# REGENXBIO Inc.: Form 8-K, filed Jun 13, 2024

- Company: [REGENXBIO Inc.](/companies/rgnx.md) (CIK 1590877)
- Form: 8-K
- Filed: 2024-06-13
- Accepted by EDGAR: Jun 12, 2024, 20:46 ET
- Period: 2024-06-12
- Accession: 0001193125-24-160146
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590877/000119312524160146/d718851d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590877/000119312524160146/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590877/000119312524160146/d718851d8k.htm

Filed Jun 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-160146. Last ingested by Listed: Nov 5, 2026, 12:01 ET. No prices; not investment advice.